<DOC>
	<DOCNO>NCT02540824</DOCNO>
	<brief_summary>RET fusion present 1 % 2 % unselected population non-small cell lung cancer ( NSCLC ) . Existing US Food Drug Administration-approved inhibitor RET tyrosine kinase show promising therapeutic effect non-small cell lung cancer patient . Apatinib oral multi-kinase inhibitor include RET fusion . This study design evaluate safety tolerability Apatinib patient RET fusion positive advanced NSCLC .</brief_summary>
	<brief_title>Study Apatinib RET Fusion Positive Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description>To observe objective response rate ( ORR ) apatinib RET fusion positive pre-treated advanced NSCLC . To observe Progression free survival （PFS） . To assess overall survival ( OS ) . To assess safety tolerability . To evaluate quality life . To explore relationship biomarkers toxicity/efficacy apatinib .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Aged ≥18 ≤80 year . ECOG performance status 0 1 . Life expectancy 12 week . At least one measurable lesion exists . ( RECIST 1.1 ) Histologically cytologic confirm RET fusion positive advance Nonsmall cell lung cancer fail prior therapy . Required laboratory value include follow parameter : ANC : ≥ 1.5 x 10^9/L , Platelet count : ≥ 80 x 10^9/L , Hemoglobin : ≥ 90 g/L , Total bilirubin : ≤ 1.5 x upper limit normal , ULN , ALT AST : ≤ 1.5 x ULN , BUN creatine clearance rate : ≥ 50 mL/min LVEF : ≥ 50 % QTcF : &lt; 470 m Signed informed consent Females childbearing potential must negative serum pregnancy test . Sexually active male childbearing potential must practice contraception study . Squamous carcinoma ( include adenosquamous carcinoma ) , small cell lung cancer Subjects third space fluid control drainage method . Obvious cavity necrosis form tumor Uncontrolled hypertension Hymoptysis , 2.5ml daily Thrombosis 12 month , include pulmonary thrombosis , stroke , deep venous thrombosis Received big surgery , bone fracture ulcer 4 week Urine protein &gt; ++ , urine protein 24 hour &gt; 1.0g pregnant lactate woman Receiving antitumor therapy . Known history hypersensitivity apatinib component .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Apatinib</keyword>
	<keyword>RET</keyword>
	<keyword>gene fusion</keyword>
	<keyword>Non-small Cell Lung Cancer</keyword>
</DOC>